HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.

Press, M F; Bernstein, L; Thomas, P A; Meisner, L F; Zhou, J Y; Ma, Y; Hung, G; Robinson, R A; Harris, C; El-Naggar, A; Slamon, D J; Phillips, R N; Ross, J S; Wolman, S R; Flom, K J

Press, M F; Bernstein, L; Thomas, P A; Meisner, L F; Zhou, J Y; Ma, Y; Hung, G; Robinson, R A; Harris, C; El-Naggar, A; Slamon, D J; Phillips, R N; Ross, J S; Wolman, S R; Flom, K J.

Affiliation

Press MF; Norris Comprehensive Cancer Center and Department of Pathology, University of Southern California School of Medicine, Los Angeles, CA 90033, USA. villalob@hsc.usc.edu

J Clin Oncol ; 15(8): 2894-904, 1997 Aug.

Article in En | MEDLINE | ID: mdl-9256133

Subject(s)

Breast Neoplasms/pathology; Gene Amplification; Receptor, ErbB-2/genetics; Aged; Biomarkers, Tumor/genetics; Breast Neoplasms/genetics; Breast Neoplasms/mortality; Female; Humans; Immunoblotting; In Situ Hybridization, Fluorescence; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Sensitivity and Specificity; Survival Rate

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Gene Amplification / Receptor, ErbB-2 Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 1997 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links